Do you want to read an article? Please log in or register.
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Pleural Diseases
RECOMMENDED
Related content
RECOMMENDED
Pleural Diseases
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda MA, Klepetko W, Lacourt A, McElnay P, Maskell NA, Mutti L, Pairon JC, Van Schil P, van Meerbeeck JP, Waller D, Weder W, Cardillo G, Putora PM
doi: 10.1183/13993003.00953-2019.
ERS/EACTS statement on the management of malignant pleural effusions
Eur Respir J.
Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, Scherpereel A, Rahman NM, Cardillo G, Maskell NA
doi: 10.1183/
Pleural Diseases
Pleural effusions in hematologic malignancies and their management with indwelling pleural catheters
Curr Opin Pulm Med.
Vakil E, Jimenez CA, Faiz SA
doi: 10.1097/MCP.
RECOMMENDED
Lung Cancer
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
Lancet Respir Med.
Scagliotti GV, Gaafar R, Nowak AK, Nakano T, van Meerbeeck J, Popat S, Vogelzang NJ, Grosso F, Aboelhassan R, Jakopovic M, Ceresoli GL, Taylor P, Orlandi F, Fennell DA, Novello S, Scherpereel A, Kuribayashi K, Cedres S, Sørensen JB, Pavlakis N, Reck M, Velema D, von Wangenheim U, Kim M, Barrueco J, Tsao AS
doi: 10.1016/S2213-2600(19)30139-0.
Malignant Pleural Mesothelioma: State of the art and advanced cell therapy
Eur J Med Chem.
Facchetti G, Petrella F, Spaggiari L, Rimoldi I
doi: 10.1016/
Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma
J Thorac Oncol.
Patil NS, Righi L, Koeppen H, Zou W, Izzo S, Grosso F, Libener R, Loiacono M, Monica V, Buttigliero C, Novello S, Hegde PS, Papotti M, Kowanetz M, Scagliotti GV
doi: 10.1016/j.jtho.2017.09.1968.
RECOMMENDED
Lung Cancer
Confocal laser endomicroscopy (CLE) as a guidance tool for pleural biopsies in malignant pleural mesothelioma
Chest.
Wijmans L, Baas P, Sieburgh TE, de Bruin DM, Ghuijs PM, van de Vijver MJ, Bonta PI, Annema JT
doi: 10.1016/j.chest.2019.04.090.
Pleural Diseases
Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial
Lancet Respir Med.
Muruganandan S, Azzopardi M, Fitzgerald DB, Shrestha R, Kwan BCH, Lam DCL, De Chaneet CC, Rashid Ali MRS, Yap E, Tobin CL, Garske LA, Nguyen PT, Stanley C, Popowicz ND, Kosky C, Thomas R, Read CA, Budgeon CA, Feller-Kopman D, Maskell NA, Murray K, Lee YCG
doi: 10.1016/S2213-2600
Pleural Diseases
A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma
Cancer.
Kinoshita Y, Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Hiroshima K, Oda Y, Nabeshima K
doi: 10.1002/cncy.21928.